SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Lab gets EIR for API manufacturing plant 5

11 Apr 2020 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA), for its API manufacturing plant 5 at Miryalaguda, Nalgonda district, Telangana, indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Indicated (VAI).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Labs. Share Price

1349.60 10.25 (0.77%)
02-Jul-2026 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1877.05
Dr. Reddys Labs. 1349.60
Cipla 1462.60
Zydus Lifesciences 1098.00
Lupin 2391.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: